Literature DB >> 23441094

Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes.

John A Saunders1, Valerie M Tatard-Leitman, Jimmy Suh, Eddie N Billingslea, Timothy P Roberts, Steven J Siegel.   

Abstract

Autism is a disabling neurodevelopmental disorder characterized by social deficits, language impairment, and repetitive behaviors with few effective treatments. New evidence suggests that autism has reliable electrophysiological endophenotypes and that these measures may be caused by n-methyl-d-aspartic acid receptor (NMDAR) disruption on parvalbumin (PV)-containing interneurons. These findings could be used to create new translational biomarkers. Recent developments have allowed for cell-type selective knockout of NMDARs in order to examine the perturbations caused by disrupting specific circuits. This study examines several electrophysiological and behavioral measures disrupted in autism using a PV-selective reduction in NMDA R1 subunit. Mouse electroencephalograph (EEG) was recorded in response to auditory stimuli. Event-related potential (ERP) component amplitude and latency analysis, social testing, and premating ultrasonic vocalizations (USVs) recordings were performed. Correlations were examined between the ERP latency and behavioral measures. The N1 ERP latency was delayed, sociability was reduced, and mating USVs were impaired in PV-selective NMDA Receptor 1 Knockout (NR1 KO) as compared with wild-type mice. There was a significant correlation between N1 latency and sociability but not between N1 latency and premating USV power or T-maze performance. The increases in N1 latency, impaired sociability, and reduced vocalizations in PV-selective NR1 KO mice mimic similar changes found in autism. Electrophysiological changes correlate to reduced sociability, indicating that the local circuit mechanisms controlling N1 latency may be utilized in social function. Therefore, we propose that behavioral and electrophysiological alterations in PV-selective NR1 KO mice may serve as a useful model for therapeutic development in autism. Autism Res 2013, 6: 69-77.
© 2013 International Society for Autism Research, Wiley Periodicals, Inc. © 2013 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  NMDA receptor 1 knockout; animal models; autism; electrophysiology; endophenotype

Mesh:

Substances:

Year:  2013        PMID: 23441094      PMCID: PMC4064157          DOI: 10.1002/aur.1264

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  33 in total

Review 1.  NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2012-02-21       Impact factor: 9.306

2.  T-maze alternation in the rodent.

Authors:  Robert M J Deacon; J Nicholas P Rawlins
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.

Authors:  T B Halene; R S Ehrlichman; Y Liang; E P Christian; G J Jonak; T L Gur; J A Blendy; H C Dow; E S Brodkin; F Schneider; R C Gur; S J Siegel
Journal:  Genes Brain Behav       Date:  2009-05-08       Impact factor: 3.449

4.  Validating γ oscillations and delayed auditory responses as translational biomarkers of autism.

Authors:  Michael J Gandal; J Christopher Edgar; Richard S Ehrlichman; Mili Mehta; Timothy P L Roberts; Steven J Siegel
Journal:  Biol Psychiatry       Date:  2010-12-15       Impact factor: 13.382

5.  40- and 70-kHz vocalizations of mice (Mus musculus) during copulation.

Authors:  N R White; M Prasad; R J Barfield; J G Nyby
Journal:  Physiol Behav       Date:  1998-02-15

6.  Spectrographic analysis of the ultrasonic vocalisations of adult male and female BALB/c mice.

Authors:  Benjamin E F Gourbal; Mathieu Barthelemy; Gilles Petit; Claude Gabrion
Journal:  Naturwissenschaften       Date:  2004-07-06

7.  N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.

Authors:  R S Ehrlichman; M J Gandal; C R Maxwell; M T Lazarewicz; L H Finkel; D Contreras; B I Turetsky; S J Siegel
Journal:  Neuroscience       Date:  2008-10-28       Impact factor: 3.590

Review 8.  Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders.

Authors:  Maria Luisa Scattoni; Jacqueline Crawley; Laura Ricceri
Journal:  Neurosci Biobehav Rev       Date:  2008-08-13       Impact factor: 8.989

9.  Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice.

Authors:  Steven J Siegel; Patrick Connolly; Yuling Liang; Robert H Lenox; Raquel E Gur; Warren B Bilker; Steven J Kanes; Bruce I Turetsky
Journal:  Neuropsychopharmacology       Date:  2002-09-16       Impact factor: 7.853

10.  Transient and steady-state auditory gamma-band responses in first-degree relatives of people with autism spectrum disorder.

Authors:  Donald C Rojas; Peter D Teale; Keeran Maharajh; Eugene Kronberg; Katie Youngpeter; Lisa B Wilson; Alissa Wallace; Susan Hepburn
Journal:  Mol Autism       Date:  2011-07-05       Impact factor: 7.509

View more
  50 in total

1.  Ringing Decay of Gamma Oscillations and Transcranial Magnetic Stimulation Therapy in Autism Spectrum Disorder.

Authors:  Manuel F Casanova; Mohamed Shaban; Mohammed Ghazal; Ayman S El-Baz; Emily L Casanova; Estate M Sokhadze
Journal:  Appl Psychophysiol Biofeedback       Date:  2021-04-20

2.  Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders.

Authors:  Xiaoxiao Xu; Alan B Wells; David R O'Brien; Arye Nehorai; Joseph D Dougherty
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

Review 3.  Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy.

Authors:  X Jiang; M Lachance; E Rossignol
Journal:  Prog Brain Res       Date:  2016-06-07       Impact factor: 2.453

Review 4.  Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.

Authors:  D Sinclair; B Oranje; K A Razak; S J Siegel; S Schmid
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

5.  Severity of ASD symptoms and their correlation with the presence of copy number variations and exposure to first trimester ultrasound.

Authors:  Sara Jane Webb; Michelle M Garrison; Raphael Bernier; Abbi M McClintic; Bryan H King; Pierre D Mourad
Journal:  Autism Res       Date:  2016-09-01       Impact factor: 5.216

Review 6.  Social Preference and Glutamatergic Dysfunction: Underappreciated Prerequisites for Social Dysfunction in Schizophrenia.

Authors:  Junghee Lee; Michael F Green
Journal:  Trends Neurosci       Date:  2016-07-29       Impact factor: 13.837

Review 7.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

8.  Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.

Authors:  Eddie N Billingslea; Valerie M Tatard-Leitman; Jaynie Anguiano; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Susumu Morita; Robert E Featherstone; Pavel I Ortinski; Michael J Gandal; Robert Lin; Yuling Liang; Raquel E Gur; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Neuropsychopharmacology       Date:  2014-02-14       Impact factor: 7.853

9.  Targeting Gamma-Related Pathophysiology in Autism Spectrum Disorder Using Transcranial Electrical Stimulation: Opportunities and Challenges.

Authors:  Fae B Kayarian; Ali Jannati; Alexander Rotenberg; Emiliano Santarnecchi
Journal:  Autism Res       Date:  2020-05-28       Impact factor: 5.216

10.  Reversal of social deficits by subchronic oxytocin in two autism mouse models.

Authors:  Brian L Teng; Viktoriya D Nikolova; Natallia V Riddick; Kara L Agster; James J Crowley; Lorinda K Baker; Beverly H Koller; Cort A Pedersen; Michael B Jarstfer; Sheryl S Moy
Journal:  Neuropharmacology       Date:  2015-12-31       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.